Cannabis and Drug Use: Hidden Stroke Risks Revealed

Epidemiological evidence suggests associations between substance use disorders and risk of stroke, but whether these are due to confounding or are true yet causal relationships remain uncertain. To meta-analyse the observational evidence on illicit substance use and stroke risk and apply Mendelian Randomisation to evaluate potential causal effects of substance dependence on stroke subtypes. We conducted a systematic review and meta-analysis of studies reporting associations between illicit drug use and stroke (PROSPERO registration - CRD420251053702). The meta-analysis included 32 studies comprising more than 100 million total participants across administrative, hospital-based and population-based datasets. Pooled odds ratios (ORs) were estimated using multivariate random-effects models for ischemic and hemorrhagic subtypes. We then performed two-sample Mendelian randomisation using genome-wide association study summary statistics to examine associations between seven drug exposures and all stroke, ischemic and hemorrhagic stroke, and ischaemic stroke subtypes. Meta-analysis demonstrated significant associations of cannabis (OR 1.37, 95% confidence interval 1.14-1.65), cocaine (OR 1.96 [1.27-3.01]), and amphetamines (OR 2.22 [1.40-3.53]) with increased stroke risk, while no significant association was observed for opioids. Findings for cannabis showed some heterogeneity and small-study effects. Mendelian randomisation analyses revealed that cannabis use disorder was associated with any stroke (OR 1.11 [1.01-1.51]) and large artery stroke (OR 1.35 [1.01-1.80]), and cocaine dependence was associated with cardioembolic stroke (OR 1.08 [1.02-1.14]) and intracerebral hemorrhage (OR 1.38 [1.15-1.65]). Genetically predicted substance use disorder overall was associated with any stroke (OR 1.33 [1.02-1.72]) and intracerebral hemorrhage (OR 7.79 [3.46-17.54]). Problematic and dependent alcohol use were linked to large artery and cardioembolic stroke, whereas nicotine dependence showed no significant associations. Our findings provide consistent observational and genetic evidence that several forms of substance misuse increase stroke risk, particularly cocaine, amphetamines and cannabis. These findings suggest important public health implications for prevention strategies targeting substance use disorders to mitigate stroke risk.